OlympiAD: Phase III trial of olaparib monotherapy versus chemotherapy for patients (pts) with HER2-negative metastatic breast cancer (mBC) and a germline BRCA mutation (gBRCAm) Meeting Abstract
| Authors: | Robson, M. E.; Im, S. A.; Senkus, E.; Xu, B.; Domchek, S. M.; Masuda, N.; Delaloge, S.; Li, W.; Tung, N. M.; Armstrong, A.; Wu, W.; Goessl, C. D.; Runswick, S.; Conte, P. F. |
| Abstract Title: | OlympiAD: Phase III trial of olaparib monotherapy versus chemotherapy for patients (pts) with HER2-negative metastatic breast cancer (mBC) and a germline BRCA mutation (gBRCAm) |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 18 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-06-20 |
| Language: | English |
| ACCESSION: | WOS:000456827200005 |
| DOI: | 10.1200/JCO.2017.35.18_suppl.LBA4 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA4 -- Source: Wos |
